TLR1/2 agonist sensing by BMDCs results in increased production of the inflammatory cytokine IL-1β in the BM perivascular niche. Increased IL-1β levels are sensed by HSCs, leading to their pool expansion, biased myeloid differentiation, and reduced repopulation capacity.